Skip to main content
OpenTrials

Clinical trial condition

Paraneoplastic Syndromes

Explore clinical trials studying Paraneoplastic Syndromes. Study availability and eligibility vary by location and protocol.

344 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Paraneoplastic Syndromes trial results

Completed

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)

NCT04373265

Conditions
ACTH Syndrome, Ectopic, Adenocarcinoma, Adrenal Cortex Diseases, +27 more
Locations
  • Site #150, Stanford Cancer Center Stanford, California, United States
  • Site #007, Moffitt Cancer Center Tampa, Florida, United States
  • Site #074, University of Michigan Medical School Ann Arbor, Michigan, United States
  • Site #030 Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Study of RVT-1401 in Myasthenia Gravis (MG) Patients

NCT03863080

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • IMC/Diagnostic and Medical Clinic Mobile, Alabama, United States
  • Phoenix Neurological Associates Phoenix, Arizona, United States
  • The Neurology Center of Southern California Carlsbad, California, United States
  • UC Irvine - MDA ALS and Neuromuscular Center Orange, California, United States
View all 20 locations
View Trial Details
Completed

A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

NCT04124965

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0004 50081 Phoenix, Arizona, United States
  • Mg0004 50072 Los Angeles, California, United States
  • Mg0004 50088 Washington D.C., District of Columbia, United States
  • Mg0004 50120 Miami, Florida, United States
View all 43 locations
View Trial Details
Completed

A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness.

NCT03770403

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Investigator Site 42 Carlsbad, California, United States
  • Investigator Site 8 Los Angeles, California, United States
  • Investigator Site 33 Orange, California, United States
  • Investigator Site 21 Palo Alto, California, United States
View all 52 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

NCT03772587

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Momenta Investigational Site Phoenix, Arizona, United States
  • Momenta Investigational Site Tucson, Arizona, United States
  • Momenta Investigational Site Los Angeles, California, United States
  • Momenta Investigational Site Orange, California, United States
View all 61 locations
View Trial Details

Related conditions